AnaptysBio Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Pipeline Updates

    NEXT STORY
    Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
    PREV STORY
    Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2018 Results; Announces Changes to Senior Leadership
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    第19回iaslc世界肺癌学会議をカナダのトロントで開催

    デンバー発, Aug. 23, 2018 (GLOBE NEWSWIRE) -- イベント内容: 国際肺癌学会 (International Association for the Study ...

    author_avatar
    NASDAQ Market News

    Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.

    SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group ...

    author_avatar
    NASDAQ Market News

    Intercept Announces Winners of Practice to Policy Health Awards Program to Encourage New Research and Improve Care for People Living with PBC

    NEW YORK, April 16, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals Inc. (Nasdaq:ICPT), a clinical stage ...

    author_avatar
    NASDAQ Market News